Centro De Investigación En Alimentación Y Desarrollo, A.C. (CIAD) (Mexique)
Belinda Vallejo Galland (Mexique)
Aarón Fernando González Córdova (Mexique)
Inventeur(s)
Vallejo Galland, Belinda
Córdova, Aarón Fernando González
Figueroa, Jóse Carlos Rodríguez
Abrégé
Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.
A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
A23C 9/123 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacéesYoghourt
Centro De Investigación En Alimentación Y Desarrollo, A.C. (CIAD) (Mexique)
Belinda Vallejo Galland (Mexique)
Aarón Fernando González Córdova (Mexique)
Inventeur(s)
Vallejo Galland, Belinda
Córdova, Aarón Fernando González
Figueroa, Jóse Carlos Rodríguez
Abrégé
Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.
A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
A23C 9/123 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacéesYoghourt
Centro De Investigación En Alimentacion Y Desarrollo, A.C. (CIAD) (Mexique)
Belinda Vallejo Galland (Mexique)
Aaró Fernando González Córdova (Mexique)
Inventeur(s)
Vallejo Galland, Belinda
González Córdova, Aarón Fernando
Rodríguez Figueroa, Jóse Carlos
Abrégé
Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.
A23C 9/123 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacéesYoghourt
Centro De Investigación En Alimentación Y Desarrollo, A.C. (CIAD) (Mexique)
Belinda Vallejo Galland (Mexique)
Aarón Fernando González Córdova (Mexique)
Inventeur(s)
Galland, Belinda Vallejo
Córdova, Aarón Fernando González
Figueroa, Jóse Carlos Rodríguez
Abrégé
Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.
A23C 9/123 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacéesYoghourt
Centro De Investiagción En Alimentación Y Desarrollo, A.C. (CIAD) (Mexique)
Belinda Vallejo Galland (Mexique)
Aarón Fernando González Córdova (Mexique)
Inventeur(s)
Vallejo Galland, Belinda
Córdova, Aarón Fernando González
Figueroa, Jóse Carlos Rodríguez
Abrégé
Lactococcus lactis strains, NRRL B-50571 and NRRL B-50572, and a bacterial preparation containing the same, have the ability to produce bioactive peptides that reduce blood pressure, lower LDL-cholesterol (bad cholesterol) and present antioxidant properties for better cardiovascular health. These biologically active peptides may be produced within the food for the production of a food product, such as a functional food, or they may be produced from protein sources and subsequently added to a food as part of the formulation or as part of a food supplement or a pharmaceutical preparation.
A23C 9/123 - Préparations à base de lait fermentéTraitements utilisant des micro-organismes ou des enzymes ne comportant que des micro-organismes de la famille des lactobactériacéesYoghourt
brevets